WHO ICTRP trial
Phase III Study of ATL-962 in Obese Patients
JPRN-jRCT2080221428 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT2080221428 |
|---|---|
| Public title | Phase III Study of ATL-962 in Obese Patients |
| Scientific title | Phase III Study of ATL-962 in Obese Patients |
| Primary sponsor | Takeda Pharmaceutical Company Limited |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 3 |
| Conditions | Obesity |
| Interventions | investigational material(s) Generic name etc : ATL-962 INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : Oral |
| Registration date | Aug 4, 2011 |
| Secondary IDs | JapicCTI-111467 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: